CICAFAST

Controlled and Double Blind Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites.
Regenerative Medicine
Research
Innovation

Official Title

Controlled and Double Blind Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites

 

Objective(s) of the trial

 

The studied treatment  is a biological dressing called CICAFAST composed of fibroblasts and fetal keratinocytes in combination with a collagen matrix. The main objective of the study is to compare wound healing of CICAFAST versus conventional treatment (JELONET®)in the treatment of split-thickness skin graft donor site at D8.